medium
protein
shed
cell
use
grow
viru
anoth
sourc
antigen
actual
viru
target
immunogen
rare
sourc
misdirect
immun
respons
viru
grown
egg
egg
protein
becom
nontarget
antigen
addit
stabil
gelatin
occasion
becom
target
unwant
immun
respons
process
vaccin
product
vari
manufactur
type
adjuv
use
gener
imposs
viral
antigen
complet
purifi
tissu
cultur
product
complet
elimin
final
product
patient
problem
even
small
amount
igg
made
fetal
bovin
serum
protein
usual
harmless
howev
popul
patient
atopi
readili
make
ige
respons
often
allerg
elicit
ige
respons
nontarget
antigen
present
potenti
problem
presenc
nontarget
antigen
multipl
viral
vaccin
mean
time
patient
receiv
vaccin
contain
nontarget
antigen
nontarget
antigen
avail
restimul
immun
respons
patient
atopi
dog
hors
respond
nontarget
antigen
make
igg
also
ige
antibodi
ige
antibodi
high
affin
receptor
mast
cell
skin
nearbi
mucou
membran
intestin
tract
respiratori
tract
ige
stay
mast
cell
month
even
serum
ige
level
wane
patient
receiv
inject
vaccin
contain
nontarget
antigen
bind
ige
mast
cell
caus
degranul
typic
type
hypersensit
respons
liber
preform
mediat
histamin
stimul
product
arachidon
acid
metabolit
lipoxygenas
cyclooxygenas
pathway
leukotrien
therebi
creat
along
releas
histamin
caus
vasoact
respons
increas
capillari
permeabl
even
smooth
muscl
contract
fig
hors
dog
respons
shown
associ
advers
clinic
respons
hors
one
may
see
sign
colic
sever
instanc
respiratori
distress
circulatori
collaps
anaphylact
shock
dog
common
earli
sign
swell
urticaria
muzzl
area
system
anaphylaxi
occur
usual
one
episod
vaccin
respons
reaction
startl
owner
veterinarian
creat
dilemma
particularli
give
requir
rabi
vaccin
frick
brook
hypothes
immun
dog
atopi
canin
distemp
parvovirus
would
alter
immunoregul
ige
respons
inbr
atop
dog
coloni
use
test
hypothesi
vaccin
puppi
sensit
grass
weed
pollen
extract
seem
enhanc
product
ige
antibodi
pollen
allergen
hogenesch
colleagu
studi
group
beagl
evalu
effect
vaccin
serum
concentr
total
antigenspecif
ige
multival
vaccin
without
adjuv
fail
alter
ige
level
addit
rabi
vaccin
rabi
vaccin
alon
contain
alum
adjuv
caus
increas
ige
reactiv
vaccin
antigen
reactiv
ige
includ
nontarget
protein
tissu
cultur
fluid
bovin
serum
albumin
fibronectin
possibl
immun
vaccin
contain
alum
adjuv
would
increas
ige
antibodi
level
reactiv
allergen
patient
alreadi
sensit
examin
tater
colleagu
use
coloni
maltesebeagl
crossbr
dog
known
allerg
corn
soy
investig
monitor
ige
level
specif
allergen
immun
commonli
use
vaccin
canin
distemperadenovirusmeasl
parvoviru
parainfluenza
viru
rabi
second
experi
effect
aluminum
fig
viral
vaccin
contain
protein
residu
tissu
cultur
media
copurifi
viru
nontarget
antigen
administr
canin
distemp
vaccin
contain
nontarget
antigen
stimul
product
antibodi
igg
sometim
ige
nontarget
antigen
target
viral
antigen
immun
respons
nontarget
antigen
restimul
vaccin
contain
antigen
parvoviru
vaccin
b
initi
ige
respons
nontarget
antigen
antibodi
bind
tightli
tissu
mast
cell
fc
receptor
anoth
vaccin
contain
nontarget
antigen
given
ige
molecul
bind
antigen
crosslink
fc
receptor
trigger
degranul
mast
cell
releas
vasoact
mediat
histamin
initi
product
arachidon
acid
mediat
prostaglandin
leukotrien
caus
physiolog
effect
result
sign
type
hypersensit
may
vari
local
facial
swell
anaphylact
shock
bsa
bovin
serum
albumin
cdv
canin
distemp
vaccin
hydroxid
adjuv
alon
paramet
examin
studi
conclud
although
increas
total
ige
observ
vaccin
dog
standard
vaccin
caus
signific
increas
level
ige
specif
corn
soy
allergen
dog
previous
sensit
inocul
alum
adjuv
alon
stimul
specif
ige
respons
studi
one
conclud
vaccin
dog
concurr
allergi
may
result
worsen
allerg
condit
later
studi
ohmori
colleagu
examin
serum
dog
react
advers
vaccin
clinic
sign
relev
anaphylaxi
collaps
facial
edema
dyspnea
vomit
within
hour
vaccin
compar
sera
sera
dog
develop
vaccin
reaction
result
show
significantli
higher
ige
level
dog
react
advers
moreov
ige
reactiv
direct
protein
fetal
bovin
serum
gelatin
casein
use
stabil
group
follow
hors
period
year
determin
yearli
vaccin
west
nile
viru
would
induc
ige
respons
high
moder
nonig
respond
identifi
reactiv
ige
direct
predominantli
toward
nontarget
antigen
present
vaccin
hors
highest
level
ige
react
bovin
serum
albumin
antigenspecif
enzymelink
immunosorb
assay
intraderm
skin
test
subsequ
studi
show
administr
oligodeoxynucleotid
contain
cpg
motif
concurr
west
nile
viru
vaccin
highrespond
hors
increas
number
regulatori
cell
concurr
decreas
ige
respons
thu
demonstr
potenti
strategi
safer
immun
highigerespond
hors
advers
reaction
nontarget
antigen
also
observ
human
patient
one
studi
human
children
sri
lanka
high
level
ige
specif
bovin
serum
albumin
detect
measl
vaccin
allergi
report
describ
mumpsmeaslesrubella
andor
influenza
vaccin
reaction
patient
egg
allergi
caus
growth
target
viru
egg
incorpor
ovalbumin
vaccin
nontarget
antigen
overal
incid
vaccin
reaction
human
patient
egg
allergi
low
requir
rabi
vaccin
problemat
owner
dog
shown
allerg
reactiv
vaccin
requir
vari
state
substitut
serum
antibodi
titer
rabi
viru
may
accept
one
possibl
method
determin
vaccin
like
elicit
advers
ige
mediat
respons
perform
intraderm
skin
test
use
vaccin
simpl
test
may
allow
veterinarian
select
product
less
like
elicit
allerg
reactiv
sensit
patient
perform
test
ml
vaccin
inject
intraderm
rout
shaven
skin
later
thorax
similar
inject
perform
diluent
steril
salin
solut
neg
control
histamin
posit
control
inject
site
observ
wheal
develop
measur
minut
presenc
wheal
vaccin
site
indic
posit
respons
vaccin
vaccin
contain
one
antigen
abl
stimul
ige
present
tissu
mast
cell
patient
although
immedi
type
igemedi
respons
vaccineassoci
nontarget
allergen
seriou
less
seriou
annoy
respons
gershwin
vaccin
also
occur
arthu
reaction
mediat
immun
complex
typic
type
iii
hypersensit
respons
typic
arthu
reaction
occur
within
hour
vaccin
given
local
inject
site
area
becom
swollen
pain
histolog
examin
tissu
show
vascul
infiltr
neutrophil
sometim
local
hemorrhag
also
featur
respons
respons
occur
circul
igg
specif
either
target
nontarget
antigen
antigen
inject
tissu
immun
complex
form
within
around
dermal
blood
vessel
fixat
complement
complex
caus
product
chemotact
factor
caus
degranul
mast
cell
neutrophil
chemotaxi
fig
result
inflamm
lead
swell
pain
area
gener
day
lesion
resolv
howev
lesson
learn
often
patient
like
need
anoth
booster
immun
near
futur
older
patient
possibl
determin
titer
vaccin
target
antigen
logic
step
toward
decid
revaccin
patient
arthu
reaction
differenti
adjuv
reaction
like
vaccineinduc
anaphylaxi
develop
fibrosarcoma
respons
vaccin
cat
rare
estim
vaccin
cat
nonetheless
cat
affect
patient
pet
statist
particularli
comfort
develop
fibrosarcoma
inject
site
vaccin
began
recogn
administr
adjuv
kill
vaccin
rabi
felin
leukemia
associ
develop
tumor
year
varieti
studi
perform
determin
caus
respons
associ
host
vaccin
factor
vaccin
associ
felin
sarcoma
task
forc
initi
result
chang
felin
vaccin
protocol
procedur
nonadjuv
rabi
vaccin
cat
subsequ
becam
avail
accord
recent
studi
canada
incid
postvaccin
fibrosarcoma
shown
signific
declin
one
result
recognit
vaccineassoci
fibrosarcoma
cat
effort
put
vaccin
specif
site
felin
leukemia
far
left
leg
possibl
rabi
far
right
leg
possibl
process
serv
two
purpos
determin
vaccin
causal
event
tumor
occur
make
possibl
save
anim
life
leg
amput
tumor
occur
administr
vaccin
intrascapular
area
make
nearli
imposs
surgic
remov
tumor
site
patient
vaccin
particular
pathogen
expos
pathogen
vaccin
effect
patient
either
develop
diseas
perhap
develop
mild
form
diseas
instanc
vaccin
fail
protect
actual
caus
sever
diseas
would
expect
unvaccin
patient
caus
vaccineinduc
diseas
enhanc
induct
immun
respons
pathogen
rather
protect
type
respons
document
first
human
children
inocul
formalininactiv
alum
adjuv
respiratori
syncyti
viru
vaccin
bovin
respiratori
syncyti
viru
vaccin
calv
research
shown
latter
case
kill
vaccin
stimul
strong
thelper
type
respons
predomin
interleukin
il
product
ige
antibodi
direct
advers
reaction
vaccin
viral
protein
viral
clearanc
effect
immun
respons
thelper
type
respons
product
interferon
gamma
research
perform
use
cotton
rat
mice
model
shown
immun
system
first
encount
respiratori
syncyti
virusbovin
respiratori
syncyti
viru
kill
virion
modul
immun
respons
favor
thelper
type
fig
clinic
syndrom
call
arthu
reaction
result
local
type
iii
hypersensit
reaction
arthu
reaction
usual
seen
anim
vaccin
mani
time
eg
older
dog
yearli
vaccin
mani
year
patient
made
high
level
igg
antibodi
vaccin
antigen
igg
interstiti
tissu
fluid
blood
vaccin
antigen
introduc
bind
antibodi
creat
immun
complex
complement
fix
produc
small
byproduct
complement
fixat
caus
mast
cell
degranul
releas
histamin
consequ
increas
permeabl
local
blood
vessel
allow
igg
leav
blood
vessel
allow
immun
complex
penetr
vessel
wall
chemotaxi
neutrophil
also
stimul
chemotact
factor
accumul
neutrophil
occur
area
inject
end
result
inflam
swollen
area
appear
hour
inject
last
sever
day
respons
wherea
first
encount
live
live
attenu
viru
balanc
immun
respons
result
recent
research
respiratori
syncyti
viru
vaccin
use
cotton
rat
model
shown
viral
antigen
inert
eg
subunit
fusion
protein
dose
import
factor
determin
whether
vaccin
exacerb
occur
group
found
also
true
formalin
inactiv
alum
adjuv
bovin
respiratori
syncyti
viru
vaccin
felin
infecti
periton
fip
anoth
diseas
associ
vaccineinduc
enhanc
fip
caus
coronaviru
thought
mutat
common
felin
enter
coronaviru
pathogenesi
fip
complex
recent
data
suggest
macrophag
play
import
role
harbor
propag
viru
vaccin
fip
previous
market
induc
igg
viru
mani
infecti
agent
would
protect
howev
fip
antibodi
opson
virion
enhanc
phagocytosi
macrophag
thu
facilit
spread
viru
within
cat
dengu
tropic
diseas
affect
human
fip
also
associ
antibodydepend
enhanc
diseas
presenc
nonneutr
igg
human
patient
infect
dengu
viru
progress
hemorrhag
fever
dengu
shock
syndrom
current
accept
explan
pathogenesi
involv
opson
viru
nonneutr
igg
subsequ
immun
complex
bind
fc
receptor
enhanc
cell
infect
caus
improv
phagocytosi
cat
infect
fip
viru
type
passiv
immun
fip
antibodi
viru
type
significantli
lower
surviv
rate
cat
receiv
passiv
antibodi
spike
protein
target
neutral
antibodi
product
recombin
vaccinia
viru
vector
vaccin
contain
gene
code
protein
test
kitten
subsequ
infect
virul
fip
vaccin
kitten
die
earlier
similarli
infect
control
kitten
anoth
studi
dna
vaccin
use
attempt
induc
cellmedi
immun
respons
fip
viru
codeliveri
plasmid
contain
nucleocapsid
n
membran
protein
use
primeboost
schedul
virul
fip
challeng
infect
kitten
receiv
vaccin
contain
gene
shorter
surviv
time
receiv
plasmid
code
two
fip
antigen
n
without
thu
suggest
degre
enhanc
recent
year
much
conjectur
case
histori
suggest
possibl
connect
overstimul
immun
respons
excess
vaccin
develop
autoimmun
diseas
immunemedi
anemia
evid
scant
studi
substanti
connect
control
retrospect
studi
dog
develop
immunemedi
hemolyt
anemia
imha
compar
dog
develop
imha
within
month
vaccin
dog
develop
imha
month
vaccin
studi
found
signific
number
studi
dog
develop
imha
within
month
vaccin
mean
number
day
postvaccin
day
contrast
control
group
dog
show
associ
vaccin
develop
imha
vaccin
use
studi
common
distemp
hepat
parvoviru
leptospirosi
bacterin
bordetella
bronchiseptica
bacterin
varieti
pharmaceut
supplier
author
conclud
studi
defin
tempor
associ
vaccin
dog
commonli
use
vaccin
develop
imha
contrast
sever
publish
studi
fail
associ
vaccin
advers
reaction
vaccin
develop
imha
dog
includ
studi
carr
colleagu
group
dog
imha
compar
dog
vaccin
control
group
signific
differ
found
tempor
relationship
vaccin
initi
diseas
examin
autoimmun
diseas
dog
associ
certain
genet
haplotyp
thu
surpris
one
see
autoimmun
diseas
certain
breed
exampl
samoy
much
higher
chanc
develop
diabet
mellitu
breed
autoimmun
thyroid
common
labrador
retriev
although
autoimmun
diseas
direct
connect
particular
infect
instig
factor
case
factor
contribut
develop
autoimmun
respons
like
multipl
part
unknown
notion
vaccin
caus
autoimmun
almost
certainli
fals
howev
like
combin
genet
environment
factor
overstimul
immun
system
occur
result
overvaccin
contribut
develop
mani
autoimmun
diseas
uncommon
hear
case
histori
middleag
dog
yearli
vaccin
sinc
puppyhood
develop
acut
hemolyt
anemia
week
visit
veterinarian
annual
booster
vaccin
patient
stimul
cytokin
storm
multipl
vaccin
antigen
adjuv
could
provid
tcell
help
b
cell
selfreact
normal
kept
check
result
absenc
tcell
help
concept
bystand
cell
activ
suggest
potenti
result
overstimul
immun
system
inject
multipl
vaccin
often
everi
month
cytokin
product
local
microenviron
lymphoid
tissu
may
lead
promiscu
stimul
potenti
autoreact
b
cell
selftoler
achiev
remov
selfreact
cell
thymu
fetal
develop
toler
level
b
cell
often
maintain
absenc
tcell
help
acquisit
tcell
help
selfreact
b
cell
may
caus
autoantibodi
product
subsequ
autoimmun
diseas
one
studi
presenc
antithyroglobulin
antibodi
routin
vaccin
examin
pet
dog
research
beagl
hypothyroid
one
common
autoimmun
diseas
human
dog
estim
hypothyroid
dog
autoimmun
thyroid
studi
research
dog
pet
dog
follow
vaccin
multival
vaccin
without
rabi
vaccin
research
dog
vaccin
seven
time
week
age
everi
month
year
age
much
frequent
recommend
pet
dog
older
year
age
receiv
booster
vaccin
check
day
later
thyroid
profil
consist
thyroidstimul
hormon
level
baselin
complet
blood
count
blood
chemistri
perform
addit
antibodi
bovin
canin
thyroglobulin
evalu
antibovin
anticanin
thyroglobulin
antibodi
found
sera
vaccin
dog
pet
dog
anticanin
thyroglobulin
antibodi
significantli
increas
specif
bovin
thyroglobulin
dog
receiv
multival
vaccin
without
kill
alum
adjuv
rabi
vaccin
show
signific
increas
antithyroglobulin
antibodi
compar
unvaccin
control
anim
dog
receiv
rabi
vaccin
show
signific
differ
group
receiv
rabi
vaccin
known
correl
develop
autoimmun
thyroid
role
antibodi
pathogenesi
canin
hashimoto
thyroid
still
debat
howev
author
suggest
presenc
bovin
thyroglobulin
fetal
bovin
serum
use
assist
cell
cultur
propag
may
play
role
vaccineinduc
stimul
immun
respons
stimul
antibodi
canin
thyroglobulin
immun
bovin
thyroglobulin
inadvert
vaccin
nontarget
antigen
could
solicit
tcell
help
selfreact
b
cell
exposur
crossreact
epitop
fig
fig
autoimmun
thyroid
hashimoto
thyroid
occur
activ
lymphocyt
attack
thyroid
gland
caus
cell
necrosi
product
antibodi
specif
thyroid
antigen
usual
anoth
featur
diseas
result
destruct
glandular
tissu
caus
lack
thyroid
hormon
thyroxin
clinic
sign
relev
hypothyroid
state
one
hypothesi
occur
presenc
bovin
thyroglobulin
vaccin
nontarget
antigen
stimul
crossreact
epitop
canin
thyroid
recruit
autoreact
cell
mediat
immun
destruct
diseas
common
certain
dog
breed
thu
genet
undoubtedli
influenc
respons
link
autoimmun
diseas
genet
well
establish
exampl
known
person
major
histocompat
complex
allel
strong
likelihood
develop
autoimmun
diseas
ankylos
spondyl
canin
histocompat
antigen
dla
link
varieti
autoimmun
diseas
rel
risk
develop
mani
current
recogn
autoimmun
diseas
dog
higher
dog
certain
dla
haplotyp
notabl
increas
incid
particular
autoimmun
diseas
specif
breed
led
analysi
dla
haplotyp
associ
high
incid
diabet
mellitu
samoy
dog
compar
rare
occurr
diseas
boxer
breed
led
evalu
case
control
reveal
dla
dq
haplotyp
significantli
reduc
case
diabet
mellitu
anoth
studi
cocker
spaniel
breed
increas
incid
imha
evalu
dla
haplotyp
preval
imha
affect
unaffect
cocker
spaniel
evalu
signific
differ
identifi
howev
studi
identifi
german
shepherd
dog
pembrok
welsh
corgi
duplic
risk
allel
exocrin
pancreat
insuffici
nova
scotia
duck
toll
retriev
predispos
immunemedi
diseas
resembl
system
lupu
erythematosu
human
associ
dla
class
ii
haplotyp
found
highli
signific
develop
lupuslik
syndrom
homozyg
dog
recent
year
veterinari
profess
taken
closer
look
durat
immun
core
canin
felin
vaccin
studi
publish
confirm
longer
durat
immun
last
least
year
core
vaccin
inform
instig
chang
vaccin
recommend
american
veterinari
medic
associ
american
anim
hospit
associ
associ
felin
practition
determin
puppykitten
vaccin
booster
subsequ
year
core
vaccin
need
given
everi
year
schedul
expect
reduc
unnecessari
immun
stimul
frequent
vaccin
factor
develop
autoimmun
incid
diseas
may
expect
decreas
increas
research
creat
better
knowledg
genet
predisposit
autoimmun
diseas
particular
dog
breed
coupl
alter
pattern
vaccin
like
key
prevent
advers
interact
vaccin
practic
canin
genet
factor
articl
varieti
potenti
detriment
effect
vaccin
describ
import
veterinarian
awar
appropri
modif
immun
scheme
individu
patient
need
howev
must
emphas
number
pet
suffer
vaccin
reaction
extrem
low
avail
vaccin
safe
efficaci
vaccin
anim
companion
import
part
overal
health
program
conduct
accord
current
standard
